Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...

After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials. Isomorphic Labs, the ...

Most U.S. adults find the information to be at least somewhat reliable, new research shows. But experts say there is ...

Although patients and the general public were identified as the primary audience, the researchers noted that AI-generated ...

At least 15,000 healthcare professionals across Vietnam will benefit from the “AI Opportunity for Healthcare Professionals” ...

Google DeepMind researchers believe that by building for India's linguistic, economic, and cultural complexity, their work ...

Google's new AI features, automated business calls, Gemini 2.5 Pro, and Deep Search, enhancing everyday Search for US users.

Artificial intelligence startup OpenEvidence banked a $210 million series B round as it looks to expand its strategic content ...

Google has created the Consumer Health Advisory Panel, a group of external experts tasked with guiding the company’s development of health-focused technologies. According to a July 15 news release ...

OpenEvidence raises $210M on $3.5B valuation to expand AI-powered medical search and decision tools - SiliconANGLE ...

Google DeepMind subsidiary, Isomorphic Labs, has said it is ready to conduct human trials for drugs developed using its AlphaFold AI technology.